NuCana PLC ADR (NCNA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

3 LOCHSIDE WAY EDINBURGH, UNITED KINGDOM EH12 9DT

NuCana plc operates as a biotechnology company. The Company develops anti-cancer medicines for ovarian, biliary, pancreatic, colorectal, haematology, oncology, and breast cancers. NuCana produces oncology medicines using a proprietary technology platform for cancer patients. NuCana serves customers in the United Kingdom and the United States.

Data as of 2020-05-30
Market Cap203.643 Million Shares Outstanding32.479 Million Avg 30-day Volume76.411 Thousand
P/E Ratio Dividend Yield EPS-0.83
Price/Sales Price cash flow ratio Price free cash flow ratio-6.1
Book Value2.29 Price to Tangible Book2.95 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low14.0316 / 3.81 Stddev
View SEC Filings from NCNA instead.

Funds Holding NCNA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NCNA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments